|
1
|
Sahakyan MA, Kim SC, Kleive D, Kazaryan
AM, Song KB, Ignjatovic D, Buanes T, Røsok BI, Labori KJ and Edwin
B: Laparoscopic distal pancreatectomy for pancreatic ductal
adenocarcinoma: Long-term oncologic outcomes after standard
resection. Surgery. 162:802–811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hwang CI, Boj SF, Clevers H and Tuveson
DA: Preclinical models of pancreatic ductal adenocarcinoma. J
Pathol. 238:197–204. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dunne RF and Hezel AF: Genetics and
biology of pancreatic ductal adenocarcinoma. Hematol Oncol Clin
North Am. 29:595–608. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rahib L, Smith BD, Aizenberg R, Rosenzweig
AB, Fleshman JM and Matrisian LM: Projecting cancer incidence and
deaths to 2030: The unexpected burden of thyroid, liver, and
pancreas cancers in the United States. Cancer Res. 74:2913–2921.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Moffitt RA, Marayati R, Flate EL, Volmar
KE, Loeza SG, Hoadley KA, Rashid NU, Williams LA, Eaton SC, Chung
AH, et al: Virtual microdissection identifies distinct tumor- and
stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat
Genet. 47:1168–1178. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Delpu Y, Hanoun N, Lulka H, Sicard F,
Selves J, Buscail L, Torrisani J and Cordelier P: Genetic and
epigenetic alterations in pancreatic carcinogenesis. Curr Genomics.
12:15–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Imaoka H, Toiyama Y, Okigami M, Yasuda H,
Saigusa S, Ohi M, Tanaka K, Inoue Y, Mohri Y and Kusunoki M:
Circulating microRNA-203 predicts metastases, early recurrence, and
poor prognosis in human gastric cancer. Gastric Cancer. 19:744–753.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Catalanotto C, Cogoni C and Zardo G:
MicroRNA in control of gene expression: An overview of nuclear
functions. Int J Mol Sci. 17:E17122016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tüfekci KU, Meuwissen RL and Genç S: The
role of microRNAs in biological processes. Methods Mol Biol.
1107:15–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang HD, Jiang LH, Sun DW, Li J and Tang
JH: MiR-139-5p: Promising biomarker for cancer. Tumour Biol.
36:1355–1365. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yonemori M, Seki N, Yoshino H, Matsushita
R, Miyamoto K, Nakagawa M and Enokida H: Dual tumor-suppressors
miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in
bladder cancer. Cancer Sci. 107:1233–1242. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun C, Sang M, Li S, Sun X, Yang C, Xi Y,
Wang L, Zhang F, Bi Y, Fu Y and Li D: Hsa-miR-139-5p inhibits
proliferation and causes apoptosis associated with down-regulation
of c-Met. Oncotarget. 6:39756–39792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hua S, Lei L, Deng L, Weng X, Liu C, Qi X,
Wang S, Zhang D, Zou X, Cao C, et al: miR-139-5p inhibits aerobic
glycolysis, cell proliferation, migration, and invasion in
hepatocellular carcinoma via a reciprocal regulatory interaction
with ETS1. Oncogene. 37:1624–1636. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Q, Liang X, Wang Y, Meng X, Xu Y, Cai
S, Wang Z, Liu J and Cai G: miR-139-5p inhibits the
epithelial-mesenchymal transition and enhances the chemotherapeutic
sensitivity of colorectal cancer cells by downregulating BCL2. Sci
Rep. 6:271572016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Agosta C, Laugier J, Guyon L, Denis J,
Bertherat J, Libé R, Boisson B, Sturm N, Feige JJ, Chabre O and
Cherradi N: MiR-483-5p and miR-139-5p promote aggressiveness by
targeting N-myc downstream-regulated gene family members in
adrenocortical cancer. Int J Cancer. 143:944–957. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li J, Su L, Gong YY, Ding ML, Hong SB, Yu
S and Xiao HP: Downregulation of miR-139-5p contributes to the
antiapoptotic effect of liraglutide on the diabetic rat pancreas
and INS-1 cells by targeting IRS1. PLoS One. 12:e01735762017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marrero-Rodríguez D, Taniguchi-Ponciano K,
Lopez-Sleman J, Romero-Morelos P, Mendoza-Rodríguez M, Garcia I,
Huerta-Padilla V, Mantilla A, Duarte A, Piña P, et al: Thymopoietin
beta and gamma isoforms as a potential diagnostic molecular marker
for breast cancer: Preliminary data. Pathol Oncol Res.
21:1045–1050. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gesson K, Vidak S and Foisner R:
Lamina-associated polypeptide (LAP)2α and nucleoplasmic lamins in
adult stem cell regulation and disease. Semin Cell Dev Biol.
29:116–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dechat T, Vlcek S and Foisner R: Review:
Lamina-associated polypeptide 2 isoforms and related proteins in
cell cycle-dependent nuclear structure dynamics. J Struct Biol.
129:335–345. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang L, Wang G, Chen S, Ding J, Ju S, Cao
H and Tian H: Depletion of thymopoietin inhibits proliferation and
induces cell cycle arrest/apoptosis in glioblastoma cells. World J
Surg Oncol. 14:2672016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim HJ, Hwang SH, Han ME, Baek S, Sim HE,
Yoon S, Baek SY, Kim BS, Kim JH, Kim SY and Oh SO: LAP2 is widely
overexpressed in diverse digestive tract cancers and regulates
motility of cancer cells. PLoS One. 7:e394822012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jung H, Lee HH, Song KY, Jeon HM and Park
CH: Validation of the seventh edition of the American Joint
Committee on Cancer TNM staging system for gastric cancer. Cancer.
117:2371–2378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ferreira HJ and Esteller M: Non-coding
RNAs, epigenetics, and cancer: Tying it all together. Cancer
Metastasis Rev. 37:55–73. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan H, Bonasio R, Simola DF, Liebig J,
Berger SL and Reinberg D: DNA methylation in social insects: How
epigenetics can control behavior and longevity. Annu Rev Entomol.
60:435–452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Piletič K and Kunej T: MicroRNA epigenetic
signatures in human disease. Arch Toxicol. 90:2405–2419. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miyoshi J, Toden S, Yoshida K, Toiyama Y,
Alberts SR, Kusunoki M, Sinicrope FA and Goel A: MiR-139-5p as a
novel serum biomarker for recurrence and metastasis in colorectal
cancer. Sci Rep. 7:433932017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Furukawa K: LAP2 binding protein 1
(L2BP1/BAF) is a candidate mediator of LAP2-chromatin interaction.
J Cell Sci. 112:2485–2492. 1999.PubMed/NCBI
|
|
31
|
Gant TM, Harris CA and Wilson KL: Roles of
LAP2 proteins in nuclear assembly and DNA replication: Truncated
LAP2beta proteins alter lamina assembly, envelope formation,
nuclear size, and DNA replication efficiency in Xenopus
laevis extracts. J Cell Biol. 144:1083–1096. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dorner D, Vlcek S, Foeger N, Gajewski A,
Makolm C, Gotzmann J, Hutchison CJ and Foisner R: Lamina-associated
polypeptide 2alpha regulates cell cycle progression and
differentiation via the retinoblastoma-E2F pathway. J Cell Biol.
173:83–93. 2006. View Article : Google Scholar : PubMed/NCBI
|
